Aperio Group, LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$166,000
+62.7%
15,721
+10.2%
0.00%
+100.0%
Q3 2015$102,000
-57.7%
14,270
+7.2%
0.00%
-50.0%
Q2 2015$241,000
+51.6%
13,312
+31.9%
0.00%0.0%
Q1 2015$159,000
-31.5%
10,095
+29.5%
0.00%
-33.3%
Q2 2014$232,000
+14.3%
7,796
+57.1%
0.00%
-25.0%
Q3 2013$203,0004,9630.00%
Other shareholders
THERAVANCE INC shareholders Q3 2013
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders